Friday, August 28 at 15:00 BST | 16:00 CEST | 10:00 EDT | 07:00 PDT

Thyroid disorders, including differentiated thyroid cancer and autoimmune thyroid disease, affect millions of patients worldwide and place a growing burden on healthcare systems. As testing volumes increase and clinical pathways evolve, consistent interpretation of results aligned with evidence-based guidelines remains a key challenge for both clinicians and laboratorians.

To address this need, this SelectScience® webinar, presented by Dr. Ossama M. Lashin, Cleveland Clinic, will begin with an educational overview of key updates from the 2025 American Thyroid Association (ATA) guidelines, focusing on how these recommendations inform contemporary thyroid disease evaluation, risk stratification, and long-term monitoring strategies.

The webinar will then explore the clinical utility of thyroglobulin and anti thyroglobulin testing, highlighting their role in disease surveillance for differentiated thyroid cancer and their relevance in autoimmune thyroid disease. Real world clinical examples will be used to illustrate how guideline anchored testing strategies can support confident clinical decision making and improve diagnostic consistency.

In conclusion, Dr. Lashin will present a clinically oriented, integrated approach to elevating thyroid health, connecting ATA guideline recommendations with practical testing considerations spanning disease assessment, longitudinal monitoring, and outcome focused patient management.

Who should attend?

This event is perfect for:

  • Endocrinology medicine specialists
  • Clinical pathologists and laboratory directors
  • Clinical chemists and medical technologists
  • Hospital administrators and care coordinators
  • Researchers and healthcare policymakers
  • Medical science liaisons and medical affairs professionals
  • Professionals involved in diagnostic test implementation or differentiated thyroid cancer risk stratification

What will this webinar cover?

Key learning objectives:

  • Describe key updates from the 2025 American Thyroid Association guidelines and explain how these recommendations inform current approaches to thyroid disease evaluation, risk stratification, and long-term monitoring.
  • Explain the clinical role of thyroglobulin and anti thyroglobulin testing in the management of differentiated thyroid cancer and autoimmune thyroid disease, including appropriate use in disease surveillance and result interpretation.
  • Apply guideline aligned testing principles to clinical scenarios to support consistent interpretation of results and informed decision making across disease assessment and longitudinal patient monitoring.

Accreditation statement

SelectScience® is approved as a provider of continuing education programs in the clinical laboratory sciences by the ASCLS P.A.C.E.® Program.

Webinar details

  • Cost: Free to attend
  • Location: Online
  • Duration: 60 minutes
  • Instruction level: Intermediate

Registration is required to secure your place. If you register but can’t attend live, you will receive a link to the on‑demand recording once it becomes available.



Presenters

Dr. Ossama M. Lashin, MD, Ph.D.
Dr. Ossama M. Lashin, MD, Ph.D.
Dr. Ossama M. Lashin is a clinician-scientist and academic endocrinologist specializing in thyroid disorders, thyroid cancer, and autoimmune thyroid disease. He serves as Medical Director of the Cleveland Clinic Thyroid Center of Excellence and Clinical Assistant Professor at the Cleveland Clinic Lerner College of Medicine of Case Western Reserve University. In these roles, Dr. Lashin leads enterprise initiatives to standardize thyroid care, build multidisciplinary pathways with endocrine surgery, ENT, oncology, and pathology, and improve outcomes for complex disease. As Regional Medical Director for Endocrinology (West Ohio), he oversees operations across ten Family Health Centers and three hospitals, supervising 16 physicians and 11 APPs. Dr. Lashin’s research focuses on outcomes, innovation, translational endocrinology, and multicenter trials.
Lucy Lawrence
Lucy Lawrence

Science Editor

SelectScience

Register

Note: By completing this form, you will receive a free membership to SelectScience® and The Scientists’ Channel®. SelectScience is a trade organisation, we do not provide services to consumers and membership is for business purposes only. As a member you must provide us with a corporate email address to enable us (and our advertisers and sponsors) to contact you for marketing purposes. You can opt-out of marketing at any time. See our Privacy Policy

(*) denotes required form field(s)

Our registration process uses cookies, by submitting this registration form you agree to our cookie policy.

* Required Fields